Clinical Trial

Repeat Late GDM Testing and Cesarean Delivery Rates

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this randomized trial is determine if re-testing for gestational diabetes in the third trimester after an ultrasound measurement of estimated fetal weight (EFW) or abdominal circumference greater than 90%ile decreases cesarean delivery rate, and to evaluate the optimal method of re-testing. The main question it aims to answer is: Does repeat testing for gestational diabetes and management of hyperglycemia decrease the cesarean delivery rate in fetuses measuring \>90%ile by estimated fetal weight (EFW) or abdominal circumference (AC) on ultrasound in the third trimester. Participants will be randomized into two groups: Group 1 will undergo a repeat glucose tolerance test (GTT) with blinded continuous glucose monitor (CGM) and group 2 will have no intervention. Participants in group 1 will receive nutrition counseling as this would be standard in patients at high risk for gestational diabetes.
Trial Details
NCT Number NCT07708129
Lead Sponsor Shauna F. Williams, MD
Conditions Large for Gestational Age (LGA), Pregnancy
Enrollment 144 participants
Start Date 2026-08-01
Primary Completion 2028-04-30 (estimated)
Study Completion 2028-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-16